New Developments in Pharmacological Treatment of Obesity and Type 2 DiabetesBeyond and within GLP 1 Receptor Agonists Cagrilintide (AM833) Long acting amylin analog. Beta cells make TWO hormones: insulin and amylin. Amylin slows stomach emptying and reduces appetite. Cagrilintide is a long acting synthetic amylin designed for once weekly dosing BPC 157 Ascend Bio Labs Cagrilintide Mini Tool Kit Peptide Tracker + Supplies List Research based Protocol Support Digital Download Etsy Israel Noninsulin Therapies in Management of Type 1 Diabetes Endocrine Practice Structural and dynamic features of cagrilintide binding to calcitonin and amylin receptors Nature Communications